Your browser doesn't support javascript.
loading
Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study.
Vianello, Eleonora; Gonzalez-Dias, Patricia; van Veen, Suzanne; Engele, Carmen G; Quinten, Edwin; Monath, Thomas P; Medaglini, Donata; Santoro, Francesco; Huttner, Angela; Dubey, Sheri; Eichberg, Michael; Ndungu, Francis M; Kremsner, Peter G; Essone, Paulin N; Agnandji, Selidji Todagbe; Siegrist, Claire-Anne; Nakaya, Helder I; Ottenhoff, Tom H M; Haks, Mariëlle C.
Afiliação
  • Vianello E; Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands. Electronic address: e.vianello@lumc.nl.
  • Gonzalez-Dias P; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
  • van Veen S; Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
  • Engele CG; Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
  • Quinten E; Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
  • Monath TP; NewLink Genetics Corporation, Devens, MA, USA.
  • Medaglini D; Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, Siena, Italy; Sclavo Vaccines Association, Siena, Italy.
  • Santoro F; Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Huttner A; Division of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland; Center for Vaccinology, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
  • Dubey S; Department of Vaccine and Biologics Research, Merck Research Laboratories, West Point, PA, USA.
  • Eichberg M; Department of Vaccine and Biologics Research, Merck Research Laboratories, West Point, PA, USA.
  • Ndungu FM; Department of Biosciences, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
  • Kremsner PG; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon; Institut für Tropenmedizin, Universitätsklinikum Tübingen, and German Center for Infection Research, Tübingen, Germany.
  • Essone PN; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
  • Agnandji ST; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon; Institut für Tropenmedizin, Universitätsklinikum Tübingen, and German Center for Infection Research, Tübingen, Germany.
  • Siegrist CA; Division of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland; Center for Vaccinology, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
  • Nakaya HI; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; Scientific Platform Pasteur-USP, São Paulo, Brazil.
  • Ottenhoff THM; Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
  • Haks MC; Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
Lancet Microbe ; 3(2): e113-e123, 2022 02.
Article em En | MEDLINE | ID: mdl-35544042
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Vacinas contra Ebola / Ebolavirus / Estomatite Vesicular Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Africa / America do norte / Europa Idioma: En Revista: Lancet Microbe Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Vacinas contra Ebola / Ebolavirus / Estomatite Vesicular Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Africa / America do norte / Europa Idioma: En Revista: Lancet Microbe Ano de publicação: 2022 Tipo de documento: Article